Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

PublicOTCMKTS:LBIO
Date8/2010
Raised
Post IPO Valuation

General Information

CategoryBioTech
Employees

Offices

Woodland Hills, USA
21900 Burbank Blvd.
Third Floor
Woodland Hills, CA
USA

People

Founder and CEO

Acquisitions

Funding

TOTAL $23M
POST IPO FUNDING TOTAL $23M
Post IPO Equity, 10/2013
$23M

Tags

Lion Biotechnologies

Lion Biotechnologies, Inc. (OTC Markets: LBIO) today announced that it has entered into definitive agreements with institutional and other accredited investors to raise approximately $23 million in a private financing. Subscribers have agreed to purchase units consisting of either (i) one share of common stock and a warrant to purchase a share of common stock, or (ii) one share of the newly authorized Series A Convertible Preferred Stock and a warrant to purchase the number of shares of common stock initially issuable upon the conversion of the preferred stock. The shares of common stock (and accompanying warrants) will be sold at $2.00 per share, and the shares of Series A Convertible Preferred Stock (and accompanying warrants) will be sold at $1,000 per share.

Recent Milestones

Videos

Screenshots

Stock Price

Sources

  1. Genesis Biopharma Announces Completion of Merger with Lion Biotechnologies (finance.yahoo.com) [edit]
  2. Lion Biotechnologies, Inc. Eyes Approximately $23 Million in Private Financing (biospace.com) [edit]
Edit This Page
Last Edited 2/21/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy